
Centene Corporation: shareholders and insiders
Price
$72.55
November 17, 2026Market cap $35.7B
What Ploutos Investor adds for Centene
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- Profit over the last twelve months is well above what the business itself earned, because it includes large gains outside the business, such as on investments or from selling a business. The P/E is lower than the business alone would give.
Insiders and their shares
Purchases and sales by officers and directors from Nov 18, 2025 to Oct 15, 2026, from their own Form 4 filings.
Bought on the market
–
nobody
Sold on the market
$15M
2 people
From Nov 18, 2025 to Nov 18, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan0%
- The rest100%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 18, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·no buys·sold $12M by 2 people
- 2025: no buys, sold $2.6M by 1 person
- 2026: no buys, sold $12M by 2 people
- Oct 15, 2026Michael A CarsonGroup President, Medicare&SpecKind
- Sep 30, 2026Lauren M TylerDirectorKind
- Sep 30, 2026Kenneth TanjiDirectorKind
- Sep 30, 2026Theodore R. Samuels IIDirectorKind
- Sep 30, 2026Frederick H EppingerDirectorKind
- Sep 30, 2026Christopher J CoughlinDirectorKind
- Sep 15, 2026Theodore J PienkosCorporate Controller & CAOKind
- Aug 26, 2026Christopher KosterSecretary & General CounselKind
- Aug 18, 2026Christopher KosterSecretary & General CounselKind
- Jul 28, 2026Paul J DiazDirectorKind
- Jul 17, 2026Lauren M TylerDirectorKind
- Jun 30, 2026Lauren M TylerDirectorKind
- Jun 30, 2026Kenneth TanjiDirectorKind
- Jun 30, 2026Theodore R. Samuels IIDirectorKind
- Jun 30, 2026Frederick H EppingerDirectorKind
- Jun 30, 2026Christopher J CoughlinDirectorKind
- Jun 15, 2026Susan Raye SmithChief Operating OfficerKind
- Jun 10, 2026Kenneth A BurdickDirectorKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | Michael A CarsonGroup President, Medicare&Spec | 7,130 | $70.16 | $500.2K | Form 4 | |
| Sep 30, 2026 | Lauren M TylerDirector | 482 | – | – | Form 4 | |
| Sep 30, 2026 | Kenneth TanjiDirector | 603 | – | – | Form 4 | |
| Sep 30, 2026 | Theodore R. Samuels IIDirector | 583 | – | – | Form 4 | |
| Sep 30, 2026 | Frederick H EppingerDirector | 864 | – | – | Form 4 | |
| Sep 30, 2026 | Christopher J CoughlinDirector | 583 | – | – | Form 4 | |
| Sep 15, 2026 | Theodore J PienkosCorporate Controller & CAO | 1,092 | $69.41 | $75.8K | Form 4 | |
| Aug 26, 2026 | Christopher KosterSecretary & General Counsel | 56.5K | $66.90 | $3.8M | Form 4 | |
| Aug 18, 2026 | Christopher KosterSecretary & General Counsel | 47.6K | $65.36 | $3.1M | Form 4 | |
| Jul 28, 2026 | Paul J DiazDirector | 2,771 | – | – | Form 4 | |
| Jul 17, 2026 | Lauren M TylerDirector | 3,155 | – | – | Form 4 | |
| Jun 30, 2026 | Lauren M TylerDirector | 61 | – | – | Form 4 | |
| Jun 30, 2026 | Kenneth TanjiDirector | 581 | – | – | Form 4 | |
| Jun 30, 2026 | Theodore R. Samuels IIDirector | 465 | – | – | Form 4 | |
| Jun 30, 2026 | Frederick H EppingerDirector | 833 | – | – | Form 4 | |
| Jun 30, 2026 | Christopher J CoughlinDirector | 562 | – | – | Form 4 | |
| Jun 15, 2026 | Susan Raye SmithChief Operating Officer | 483 | $65.19 | $31.5K | Form 4 | |
| Jun 10, 2026 | Kenneth A BurdickDirector | 80.0K | $64.55 | $5.2M | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before May 26, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by CNC's officers and directors from 2006 up to November 17, 2025, 20 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 15 more, back to 2006
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- BlackRock, Inc.Share of class7.70%
- Vanguard Capital ManagementShare of class7.30%
- AQR Capital Management, LLCwith 1 more personShare of class6.47%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| BlackRock, Inc. | 7.70% | 38.22M | Jul 16, 2025 | 13G/A | |
| Vanguard Capital Management | 7.30% | 35.95M | Apr 29, 2026 | 13G | |
| AQR Capital Management, LLCwith 1 more person | 6.47% | 31.80M | Feb 13, 2026 | 13G |
Fell to 5% or less (4)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Greenlight / DME (Einhorn)In the quarter
- Glenview CapitalIn the quarter+25%
- AQR CapitalIn the quarter+9.5%
- Bridgewater (Dalio)In the quarter+236%
- Renaissance TechnologiesIn the quarter+79%
- Point72 (Cohen)In the quarter+113%
- D.E. ShawIn the quarter-45%
- Millennium Mgmt (Englander)In the quarter-43%
- Citadel Advisors (Griffin)In the quarter-53%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Greenlight / DME (Einhorn) | 1.65M | $103M | 2.89% | |
| Glenview Capital | 2.36M | +25% | $147M | 2.61% |
| AQR Capital | 31.40M | +9.5% | $1.9B | 0.57% |
| Bridgewater (Dalio) | 1.30M | +236% | $81M | 0.35% |
| Renaissance Technologies | 3.93M | +79% | $244M | 0.33% |
| Point72 (Cohen) | 1.45M | +113% | $90M | 0.14% |
| D.E. Shaw | 2.89M | -45% | $179M | 0.11% |
| Millennium Mgmt (Englander) | 908.1K | -43% | $56M | 0.04% |
| Citadel Advisors (Griffin) | 475.4K | -53% | $30M | 0.02% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 2.22% of its shares outstanding were held short, +4.0% since the report before.
- Shares held short
- 10.93M
- 2.22%
- Since the report before10.51M on Sep 30, 2026
- +4.0%
- 2.5
- 4.32M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 30%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 6.85M
- Nov 15, 2023: Shares held short 7.21M
- Nov 30, 2023: Shares held short 7.20M
- Dec 15, 2023: Shares held short 7.38M
- Dec 29, 2023: Shares held short 5.81M
- Jan 12, 2024: Shares held short 6.93M
- Jan 31, 2024: Shares held short 7.08M
- Feb 15, 2024: Shares held short 8.25M
- Feb 29, 2024: Shares held short 8.84M
- Mar 15, 2024: Shares held short 9.60M
- Mar 28, 2024: Shares held short 8.20M
- Apr 15, 2024: Shares held short 7.59M
- Apr 30, 2024: Shares held short 7.58M
- May 15, 2024: Shares held short 9.49M
- May 31, 2024: Shares held short 13.05M
- Jun 14, 2024: Shares held short 12.65M
- Jun 28, 2024: Shares held short 13.68M
- Jul 15, 2024: Shares held short 13.54M
- Jul 31, 2024: Shares held short 10.45M
- Aug 15, 2024: Shares held short 9.77M
- Aug 30, 2024: Shares held short 10.12M
- Sep 13, 2024: Shares held short 9.62M
- Sep 30, 2024: Shares held short 7.80M
- Oct 15, 2024: Shares held short 8.09M
- Oct 31, 2024: Shares held short 14.44M
- Nov 15, 2024: Shares held short 15.16M
- Nov 29, 2024: Shares held short 16.31M
- Dec 13, 2024: Shares held short 19.25M
- Dec 31, 2024: Shares held short 8.04M
- Jan 15, 2025: Shares held short 5.62M
- Jan 31, 2025: Shares held short 6.67M
- Feb 14, 2025: Shares held short 9.78M
- Feb 28, 2025: Shares held short 6.05M
- Mar 14, 2025: Shares held short 9.91M
- Mar 31, 2025: Shares held short 7.14M
- Apr 15, 2025: Shares held short 10.56M
- Apr 30, 2025: Shares held short 8.57M
- May 15, 2025: Shares held short 10.93M
- May 30, 2025: Shares held short 7.82M
- Jun 13, 2025: Shares held short 9.31M
- Jun 30, 2025: Shares held short 9.87M
- Jul 15, 2025: Shares held short 13.44M
- Jul 31, 2025: Shares held short 27.78M
- Aug 15, 2025: Shares held short 23.68M
- Aug 29, 2025: Shares held short 19.45M
- Sep 15, 2025: Shares held short 19.58M
- Sep 30, 2025: Shares held short 13.47M
- Oct 15, 2025: Shares held short 13.68M
- Oct 31, 2025: Shares held short 14.33M
- Nov 14, 2025: Shares held short 15.24M
- Nov 28, 2025: Shares held short 13.52M
- Dec 15, 2025: Shares held short 12.59M
- Dec 31, 2025: Shares held short 12.91M
- Jan 15, 2026: Shares held short 12.23M
- Jan 30, 2026: Shares held short 12.73M
- Feb 13, 2026: Shares held short 14.38M
- Feb 27, 2026: Shares held short 12.70M
- Mar 13, 2026: Shares held short 11.70M
- Mar 31, 2026: Shares held short 13.67M
- Apr 15, 2026: Shares held short 13.76M
- Apr 30, 2026: Shares held short 15.23M
- May 15, 2026: Shares held short 15.14M
- May 29, 2026: Shares held short 14.67M
- Jun 15, 2026: Shares held short 14.80M
- Jun 30, 2026: Shares held short 15.13M
- Jul 15, 2026: Shares held short 13.44M
- Jul 31, 2026: Shares held short 13.59M
- Aug 14, 2026: Shares held short 13.27M
- Aug 31, 2026: Shares held short 13.43M
- Sep 15, 2026: Shares held short 14.13M
- Sep 30, 2026: Shares held short 10.51M
- Oct 15, 2026: Shares held short 10.93M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading46.6% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 46.6% of the shares in the reported trades were short sales, against 48.7% in the 14 before.
- Last 14 sessionsOct 29, 2026 – Nov 17, 2026
- 46.6%
- The 14 beforeOct 9, 2026 – Oct 28, 2026
- 48.7%
- Change
- -2.1 pts
- Short sales a dayon average, of 2.19M shares
- 1.02M
- More than atof 3,666 US-listed companies, same days
- 37%
- Median of alleight in ten from 34.6% to 63.7%
- 50.3%
- Short sales
- Oct 9, 2026: Short sales 51.5%
- Oct 12, 2026: Short sales 45.2%
- Oct 13, 2026: Short sales 49.9%
- Oct 14, 2026: Short sales 45.5%
- Oct 15, 2026: Short sales 51.8%
- Oct 16, 2026: Short sales 38.4%
- Oct 19, 2026: Short sales 43.5%
- Oct 20, 2026: Short sales 40.8%
- Oct 21, 2026: Short sales 43.6%
- Oct 22, 2026: Short sales 46.3%
- Oct 23, 2026: Short sales 39%
- Oct 26, 2026: Short sales 36.2%
- Oct 27, 2026: Short sales 64.6%
- Oct 28, 2026: Short sales 56.2%
- Oct 29, 2026: Short sales 39.5%
- Oct 30, 2026: Short sales 41.9%
- Nov 2, 2026: Short sales 49.9%
- Nov 3, 2026: Short sales 37.4%
- Nov 4, 2026: Short sales 51.4%
- Nov 5, 2026: Short sales 49.5%
- Nov 6, 2026: Short sales 48.9%
- Nov 9, 2026: Short sales 39.2%
- Nov 10, 2026: Short sales 44.9%
- Nov 11, 2026: Short sales 51.6%
- Nov 12, 2026: Short sales 38.6%
- Nov 13, 2026: Short sales 51.8%
- Nov 16, 2026: Short sales 40.4%
- Nov 17, 2026: Short sales 54.8%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Sarah LondonChief Executive OfficerDirectly845.3K
- Andrew Lynn AsherChief Financial OfficerDirectly486.8K
- Frederick H EppingerDirectorDirectly370.4K
- Kenneth J FasolaPresidentDirectly300.4K
- Christopher KosterSecretary & General CounselDirectly248.9K
- Susan Raye SmithChief Operating OfficerDirectly212.2K
- Kenneth A BurdickDirectorDirectly197.1K
- Michael A CarsonGroup President, Medicare&SpecDirectly116.6K
- Theodore R. Samuels IIDirectorDirectly25.8K
- Christopher J CoughlinDirectorDirectly49.3K
- Theodore J PienkosCorporate Controller & CAODirectly28.8K
- Thomas GrecoDirectorDirectly19.3K
- Kenneth TanjiDirectorDirectly13.1K
- Lori Jean RobinsonDirectorDirectly11.5K
- Lauren M TylerDirectorDirectly3,698
- Paul J DiazDirectorDirectly2,771
- H James DallasDirectorDirectly–
- Jessica L. BlumeDirectorDirectly–
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Sarah LondonChief Executive Officer | 845.3K | – | Aug 8, 2025 | Form 4 |
| Andrew Lynn AsherChief Financial Officer | 486.8K | – | Nov 13, 2024 | Form 4 |
| Frederick H EppingerDirector | 370.4K | – | Sep 30, 2026 | Form 4 |
| Kenneth J FasolaPresident | 300.4K | – | May 13, 2024 | Form 4 |
| Christopher KosterSecretary & General Counsel | 248.9K | – | Aug 26, 2026 | Form 4 |
| Susan Raye SmithChief Operating Officer | 212.2K | – | Jun 15, 2026 | Form 4 |
| Kenneth A BurdickDirector | 197.1K | – | Jun 10, 2026 | Form 4 |
| Michael A CarsonGroup President, Medicare&Spec | 116.6K | – | Oct 15, 2026 | Form 4 |
| Theodore R. Samuels IIDirector | 25.8K | 32.0K | Sep 30, 2026 | Form 4 |
| Christopher J CoughlinDirector | 49.3K | – | Sep 30, 2026 | Form 4 |
| Theodore J PienkosCorporate Controller & CAO | 28.8K | – | Sep 15, 2026 | Form 4 |
| Thomas GrecoDirector | 19.3K | – | Dec 18, 2024 | Form 4 |
| Kenneth TanjiDirector | 13.1K | – | Sep 30, 2026 | Form 4 |
| Lori Jean RobinsonDirector | 11.5K | – | Feb 13, 2024 | Form 4 |
| Lauren M TylerDirector | 3,698 | – | Sep 30, 2026 | Form 4 |
| Paul J DiazDirector | 2,771 | – | Jul 28, 2026 | Form 4 |
| H James DallasDirector | – | 1,693 | Dec 16, 2024 | Form 4 |
| Jessica L. BlumeDirector | – | 250 | Dec 16, 2024 | Form 4 |
A lower bound: it counts only the 18 officers and directors with a market trade since Nov 19, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
Executive pay
From the Pay versus Performance table every company puts in its proxy statement since 2023: what the chief executive was paid, what was actually paid once the shares vest at year-end values, and how the stock did against the peer group the company itself picked.
$20M
Actually paid: $4.6M
$0
Actually paid: $0
$7.7M
Actually paid: $3.2M
$69
Peers: $148
Adjusted Diluted EPS
From the proxy statement (DEF 14A) of Mar 26, 2026, as filed with the SEC with structured data. Pay in dollars. The company picks its own peer group and measure. DEF 14A
Share repurchases
How many of its own shares the company bought each quarter, at what average price, for how much, and what remains of the program its board authorized, from the table it puts in every 10-Q and 10-K.
- Mar 31, 202610-QAmount$30M
- Dec 31, 202510-KAmount$2.1M
- Jun 30, 202510-QAmount$400M
- Mar 31, 202510-QAmount$41M
- Dec 31, 202410-KAmount$934M
- Sep 30, 202410-QAmount$1.2B
- Jun 30, 202410-QAmount$803M
- Mar 31, 202410-QAmount$151M
| Quarter | Shares | Average price | Amount | Left in the program | Filing |
|---|---|---|---|---|---|
| Mar 31, 202610-Q | 866.0K | $34.54 | $30M | $1.8B | 10-Q |
| Dec 31, 202510-K | 60.0K | $34.50 | $2.1M | $1.8B | 10-K |
| Jun 30, 202510-Q | 6.71M | $59.59 | $400M | $1.8B | 10-Q |
| Mar 31, 202510-Q | 705.0K | $58.80 | $41M | $2.2B | 10-Q |
| Dec 31, 202410-K | 14.44M | $64.65 | $934M | $2.2B | 10-K |
| Sep 30, 202410-Q | 16.37M | $74.91 | $1.2B | $3.2B | 10-Q |
| Jun 30, 202410-Q | 10.70M | $75.05 | $803M | $4.4B | 10-Q |
| Mar 31, 202410-Q | 1.98M | $76.17 | $151M | $5.2B | 10-Q |
From the "Issuer Purchases of Equity Securities" table of the 10-Qs and 10-Ks, read without a model. Only the quarters whose shares times average price agree with the cash the company says it paid for repurchases in its cash-flow statement are shown. The shares include those withheld for officers' taxes. A quarter with an accelerated repurchase shows the table's shares and the cash paid, without an average price. 3 filing(s) not shown, as the table was not read or did not agree with the cash.
The shareholders' vote on pay
The advisory say-on-pay vote at each annual meeting, as the company states it in the 8-K it files after the meeting: how many voted for and against the executives' pay. 90% is the norm. Under 70% proxy advisers expect the board to respond the next year.
- 2026May 15, 2026For91.6%
- 2025May 14, 2025For88.8%
- 2024May 16, 2024For90.8%
- 2023May 15, 2023For84.0%
- 2022Apr 28, 2022For33.6%
- 2021Apr 30, 2021For98.0%
| Year | For | Votes for | Votes against | Abstentions | Broker non-votes | Filing |
|---|---|---|---|---|---|---|
| 2026May 15, 2026 | 91.6% | 350M | 31.99M | 671.2K | 30.41M | 8-K |
| 2025May 14, 2025 | 88.8% | 378M | 47.51M | 927.0K | 18.33M | 8-K |
| 2024May 16, 2024 | 90.8% | 434M | 43.97M | 269.7K | 16.99M | 8-K |
| 2023May 15, 2023 | 84.0% | 408M | 77.81M | 351.7K | 20.91M | 8-K |
| 2022Apr 28, 2022 | 33.6% | 175M | 345M | 193.2K | 18.08M | 8-K |
| 2021Apr 30, 2021 | 98.0% | 509M | 10.27M | 86.6K | – | 8-K |
From the 8-K (item 5.07) the company files after each annual meeting since 2021, read from the filing's text without a model. A company that votes every three years has empty years. The vote is advisory: the board is not bound by it.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IHFiShares U.S. Healthcare Providers ETFWeight in the fund4.22%
- RPVInvesco S&P 500 Pure Value ETFWeight in the fund2.53%
- VFLOVictoryShares Free Cash Flow ETFWeight in the fund2.16%
- RWLInvesco S&P 500 Revenue ETFWeight in the fund0.96%
- AVLVAvantis U.S. Large Cap Value ETFWeight in the fund0.61%
- FMDEFidelity Enhanced Mid Cap Core ETFWeight in the fund0.56%
- SCHMSchwab U.S. Mid-Cap ETFWeight in the fund0.56%
- XLVState Street(R) Health Care Select Sector SPDR(R) ETFWeight in the fund0.52%
- IYHiShares U.S. Healthcare ETFWeight in the fund0.51%
- VLUEiShares MSCI USA Value Factor ETFWeight in the fund0.50%
57 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 851
- Q4 2025: Managers 914
- Q1 2026: Managers 871
- Q2 2026: Managers 1,004
Institutional investors by quarter
The fund managers holding CNC, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 1,004 managers held 488M shares, worth $31.3B. During the quarter 222 opened a position, 89 closed one, 342 added and 337 trimmed.
The largest holders, Q2 2026
- BlackRockIn the quarter+4.1%
- Vanguard Capital ManagementIn the quarter+0.8%
- AQR CapitalIn the quarter-15%
- Vanguard Portfolio ManagementIn the quarter+3.3%
- State StreetIn the quarter+1.5%
- Geode Capital ManagementIn the quarter+2.5%
- Wellington Management GroupIn the quarter+423%
- Ameriprise FinancialIn the quarter+23%
- InvescoIn the quarter+5.3%
- Harris Associates L PIn the quarter-21%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| BlackRock | 41.45M | +4.1% | $2.7B |
| Vanguard Capital Management | 31.48M | +0.8% | $2.0B |
| AQR Capital | 28.68M | -15% | $1.8B |
| Vanguard Portfolio Management | 22.35M | +3.3% | $1.4B |
| State Street | 21.97M | +1.5% | $1.4B |
| Geode Capital Management | 13.31M | +2.5% | $854M |
| Wellington Management Group | 13.30M | +423% | $854M |
| Ameriprise Financial | 12.42M | +23% | $798M |
| Invesco | 11.18M | +5.3% | $718M |
| Harris Associates L P | 11.12M | -21% | $714M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
The full analysis
What do Centene's filings show?
Who buys and sells is one part of Centene's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have CNC's insiders bought or sold?
From May 26, 2026 to Oct 15, 2026 Centene's insiders bought 0 and sold $12M of shares on the market. 0% of the sales were under set 10b5-1 plans.
Which well-known managers hold CNC?
9 of the managers we track held the shares on Sep 30, 2026. The largest position was AQR Capital's, worth $1.9B.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.